Cargando…
Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich’s Ascites Tumor in Mice
BACKGROUND: Dietary energy restriction (DER) has been well established as a potent anticancer strategy. Non-adoption of restricted diet for an extended period has limited its practical implementation in humans with a compelling need to develop agents that mimic effects similar to DER, without reduct...
Autores principales: | Singh, Saurabh, Pandey, Sanjay, Bhatt, Anant Narayan, Chaudhary, Richa, Bhuria, Vikas, Kalra, Namita, Soni, Ravi, Roy, Bal Gangadhar, Saluja, Daman, Dwarakanath, Bilikere S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4489743/ https://www.ncbi.nlm.nih.gov/pubmed/26135741 http://dx.doi.org/10.1371/journal.pone.0132089 |
Ejemplares similares
-
Dietary administration of the glycolytic inhibitor 2-deoxy-D-glucose reduces endotoxemia-induced inflammation and oxidative stress: Implications in PAMP-associated acute and chronic pathology
por: Pandey, Sanjay, et al.
Publicado: (2023) -
Enhanced Antitumor Immunity Contributes to the Radio-Sensitization of Ehrlich Ascites Tumor by the Glycolytic Inhibitor 2-Deoxy-D-Glucose in Mice
por: Farooque, Abdullah, et al.
Publicado: (2014) -
2-deoxy-D-Glucose-(2-DG) Prevents Pathogen Driven Acute Inflammation and Associated toxicity
por: Pandey, Sanjay, et al.
Publicado: (2020) -
Transient elevation of glycolysis confers radio-resistance by facilitating DNA repair in cells
por: Bhatt, Anant Narayan, et al.
Publicado: (2015) -
Amifostine Analog, DRDE-30, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Arora, Aastha, et al.
Publicado: (2018)